InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: studythosestocks post# 4008

Tuesday, 04/09/2013 7:03:27 PM

Tuesday, April 09, 2013 7:03:27 PM

Post# of 426487
Study
Also my understanding with NME, 3 yrs starts basically with filing (30 vs. 36).

Amarin will have 24 patents before June. This tells us two things, one...they have a great team with a plan, and two the unexpected results in the CV markers where unexpected and significant.

I expect 5 yrs of exclusivity, otherwise BE guidance for Lovaza and Vascepa would use EXACT terms "icosapent ethyl" and EPAee. Also new MAPP salt policy wouldn't exclude Esters...

Williams
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News